Zobrazeno 1 - 10
of 89
pro vyhledávání: '"DJ Pullen"'
Autor:
J J Shuster, DJ Pullen, Michael E. Harris, V J Land, Yaddanapudi Ravindranath, Robert A. Krance, D. Pinkel, W M Crist
Publikováno v:
Journal of Clinical Oncology. 12:1939-1945
PURPOSE To compare efficacy and toxicity of two schedules of intermediate-dose methotrexate (IDM) and cytarabine (Ara-C) in remission consolidation of childhood acute lymphoblastic leukemia (ALL). PATIENTS AND METHODS In 1986, the Pediatric Oncology
Autor:
Michael P. Link, Michael L. Cleary, N Hakami, DJ Pullen, Jeffrey E. Rubnitz, LS Frankel, Jonathan J. Shuster, Andrew J. Carroll
Publikováno v:
Blood. 84:570-573
chromosome band 11q23, the location of the HRX gene, is a site of recurrent translocations in human malignancies. Infants with acute lymphoblastic leukemia (ALL) commonly have 11q23 translocations and have an especially poor prognosis despite intensi
Autor:
DJ Pullen, Susana C. Raimondi, Andrew J. Carroll, M. G. Hulshof, A. M. Curcio-Brint, David R. Head, P H Domer, T. A. Motroni, James R. Downing
Publikováno v:
Blood. 83:330-335
The t(4;11)(q21;q23) is the most common translocation involving band 11q23 and is found predominantly in acute lymphoblastic leukemias (ALLs) of infants. Recent studies have shown that this translocation involves the MLL gene on chromosome 11 and the
Autor:
Jonathan J. Shuster, C. P. Steuber, Vita J. Land, DJ Pullen, Michael J. Borowitz, Andrew J. Carroll, Michael S. Watson, Frederick G. Behm
Publikováno v:
Blood. 82:3098-3102
Of 1,036 children with newly diagnosed non-T, non-B acute lymphoblastic leukemia (ALL) and a demonstrated cytogenetic abnormality treated on the frontline Pediatric Oncology Group (POG) therapeutic trial 8602, there were 33 patients with trisomy 21 a
Autor:
ML Cleary, AJ Carroll, DJ Pullen, JJ Shuster, Stephen P. Hunger, Michael J. Borowitz, CP Steuber
Publikováno v:
Blood. 82:1086-1091
The t(1;19)(q23;p13) translocation occurs in approximately 5% of B- precursor acute lymphoblastic leukemias (ALLs) occurring in children. Its presence has been associated with a poor prognosis, which may be overcome with more intensive therapy. Altho
Autor:
CH Pui, LS Frankel, AJ Carroll, SC Raimondi, JJ Shuster, DR Head, WM Crist, VJ Land, DJ Pullen, CP Steuber
Publikováno v:
Blood. 77:440-447
The t(4;11)(q21;q23) chromosomal abnormality was identified in 40 (2%) of 1,986 children with newly diagnosed acute lymphoblastic leukemia (ALL). This translocation was associated with female sex (63%), age less than 1 year (60%), hyperleukocytosis (
Autor:
DJ Pullen, Frederick G. Behm, Jonathan J. Shuster, M Whitehead, A T Look, Andrew J. Carroll, William M. Crist, D Mahoney, A Ragab, T.J. Vietti
Publikováno v:
Blood. 76:117-122
The prognostic significance of chromosomal translocations, particularly t(1;19) (q23;p13), was evaluated in children with pre-B and early pre-B acute lymphoblastic leukemia (ALL). Patients were treated on a risk- based protocol of the Pediatric Oncol
Autor:
William M. Crist, C H Pui, VJ Land, DJ Pullen, Michael J. Borowitz, Frederick G. Behm, Jonathan J. Shuster, Dorothy L. Williams, Susana C. Raimondi, Andrew J. Carroll
Publikováno v:
Blood. 75:1170-1177
Cytogenetic and DNA flow cytometric analyses of leukemic cells from 2,184 children with newly diagnosed acute lymphoblastic leukemia (ALL) identified 27 cases (1.2%) that had a hypodiploid line with fewer than 45 chromosomes per cell. Had cytogenetic
Publikováno v:
Blood. 84(2)
chromosome band 11q23, the location of the HRX gene, is a site of recurrent translocations in human malignancies. Infants with acute lymphoblastic leukemia (ALL) commonly have 11q23 translocations and have an especially poor prognosis despite intensi
Publikováno v:
Blood. 82(10)
Of 1,036 children with newly diagnosed non-T, non-B acute lymphoblastic leukemia (ALL) and a demonstrated cytogenetic abnormality treated on the frontline Pediatric Oncology Group (POG) therapeutic trial 8602, there were 33 patients with trisomy 21 a